Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-5615-05
Published October 3, 2012 · Recall initiated: July 27, 2012
Summary
FDA records drug Class II recall D-1702-2012, published October 3, 2012 and initiated July 27, 2012. Recalling firm: Mylan Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 960 bottles; Lot: Lot ZLMM12063, Exp March 2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.
What to do
Voluntary: Firm initiated · Letter
Get an email if LEVETIRACETAM has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- LEVETIRACETAM
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Distributor
- The product was distributed to KY.
- Lot
- Lot ZLMM12063, Exp March 2014
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDALevetiracetam 0.75% in Sodium Chloride Injection 1,000 mg/100 mL (10 mg/mL), 1 x 100mL, Rx Only, ManufacturedApril 23, 2025
- FDALevetiracetam Tablets USP 750 mg 120-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. 279April 22, 2020
- FDALevetiracetam in 0.54% Sodium Chloride Injection, 1,500 mg per 100 mL (15 mg/mL), For Intravenous InfusionMay 9, 2018
- FDALevetiracetam in 0.82% Sodium Chloride Injection, 500 mg per 100 mL (5 mg/mL), For Intravenous Infusion Only,May 9, 2018
- FDANAPROXEN TABLETS USP, 500 mg, 100-count Tablets per bottle, Rx only, Manufactured by: Glenmark Generics Ltd.,October 3, 2012
- FDAWhey Protein Concentrate, Net Weight: 1lb (454g)October 3, 2012
Questions about this recall
Was Levetiracetam Tablets, USP 500 mg, 500 count bottle, Rx only, Manufactured for: Mylan Pharmaceuticals Inc. Morgantown, WV 26505 USA, NDC 0378-5615-05 recalled?
Yes. FDA published recall D-1702-2012 on October 3, 2012. Reported hazard: Adulterated Presence of Foreign Tablets: Pharmaceutical manufacturer may have distributed foreign tablets in bottles of Levetiracetam Tablets, USP 500 mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: LEVETIRACETAM.